A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of BFKB8488A Compared With Placebo in Participants With Non-Alcoholic Steatohepatitis

NCT04171765 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

46

Enrollment

INDUSTRY

Sponsor class

Stopped The study was terminated due to strategic business reasons.

Conditions

Non-alcoholic Steatohepatitis

Interventions

DRUG: Placebo
DRUG: BFKB8488A

Sponsor

Genentech, Inc.